Risankizumab: Injection 150mg in 1 mL pre-filled pen, Injection 150mg in 1 mL pre-filled syringe; Skyrizi® Page last updated: 4 March 2022 Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 316KB) Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 52KB)